Browsing Tag
Afrezza
1 post
Biotech shake-up: can Dr. Ajay Ahuja’s appointment as CMO mark a turning point for MannKind?
Find out why MannKind (Nasdaq: MNKD) appointed Dr. Ajay Ahuja as chief medical officer and what this means for its pipeline and stock outlook.